摘要:
The invention relates to hybridomas producing anti-Leishmania monoclonal antibodies which are characterized by their capacity to inhibit the infection of sarcomateous cells by the promastigote forms of one or a plurality of Leishmania species when those sarcomateous cells are contacted with said promastigote forms pre-incubated with the monoclonal antibodies under conditions which, in the absence of said monoclonal antibodies, would result in a high parasitemy in said cells. These monoclonal antibodies and the proteins of parasites which they recognize may be used in operations for detecting leishmanioses.
摘要:
Hybridomes produisant des anticorps monoclonaux anti-Leishmania qui sont caractérisés par leur capacité à inhiber l'infection de cellules sarcomateuses par les formes promastigotes d'une ou plusieurs espèces de Leishmania, lorsque ces cellules sarcomateuses sont mises en contact avec lesdites formes promastigotes pré-incubées avec ces anticorps monoclonaux dans des conditions qui, en l'absence desdits anticorps monoclonaux, conduiraient à une parasitémie élevée dans lesdites cellules. Ces anticorps monoclonaux et les protéines de parasites qu'ils reconnaissent peuvent être mis en oeuvre dans des opérations de détections des leishmanioses.
摘要:
The present invention relates to a new class of compounds of the general Formula (i): wherein R 1 is selected from the group consisting of: a substituted or unsubstituted C 1 -C 10 alkyl group and a polar atom selected from the group consisting of: oxygen, nitrogen, sulfur or halogen atom; R 2 and R 3 are polar groups chosen from the group consisting of: =O, =NH, -NH 2 , -OH, =S, -X 1 wherein X 1 is a halogen atom; and isomers thereof, which can in particular be used as inhibitors of Proline Racemase, as a medicament and as a component of a pharmaceutical composition. Also disclosed are in silico methods to determine inhibitors of a target using a novel structural progression approach.
摘要:
The present invention provides the crystal structure of the Trypanosoma cruzi PRACA proline racemase. Methods of modelling drugs that treat or prevent infection by T. cruzi are also provided, as are the drugs that are identified.
摘要:
The present invention relates to a new class of compounds of the general Formula (i): wherein R 1 is selected from the group consisting of: a substituted or unsubstituted C 1 -C 10 alkyl group and a polar atom selected from the group consisting of: oxygen, nitrogen, sulfur or halogen atom; R 2 and R 3 are polar groups chosen from the group consisting of: =O, =NH, -NH 2 , -OH, =S, -X 1 wherein X 1 is a halogen atom; and isomers thereof, which can in particular be used as inhibitors of Proline Racemase, as a medicament and as a component of a pharmaceutical composition. Also disclosed are in silico methods to determine inhibitors of a target using a novel structural progression approach.
摘要:
The present invention provides the crystal structure of the Trypanosoma cruzi PRACA proline racemase. Methods of modelling drugs that treat or prevent infection by T. cruzi are also provided, as are the drugs that are identified.
摘要:
This invention provides identification and characterization of racemases and definition of protein signatures of these racemases. This invention also provides identification of nucleic acid molecules encoding a peptide consisting of a motif characteristic of the protein signatures, and to the peptides consisting of these motifs. Antibodies specific for the peptides and to immune complexes of these antibodies with the peptides are also provided. Further, the invention relates to methods and kits for detecting racemases using the nucleic acid molecules of the invention, as well as the peptides consisting of the motifs and antibodies to these peptides.